In this case-control study, we chose a subtype of OA, knee OA, and aimed to identify the possible association and clinical significance of MATN-3 rs8176070 (SNP6) polymorphism in a series of Egyptian patients with primary knee OA.
Material and Methods

Study approval
The study was conducted in accordance with the guidelines of the Declaration of Helsinki (World Medical Association, 2008) , and the local ethics committee of Benha University School of Medicine approved the study protocol (14) . Informed written consent was obtained from all the participants before they were enrolled in the study.
The present case-control study included 50 primary knee OA patients (Group I) fulfilling the American College of Rheumatology (ACR) classification criteria of knee OA who attended or were admitted to the rheumatology, rehabilitation, and physical medicine outpatients' clinic and inpatients' department of Benha University hospitals during the period from February 2015 to May 2015, together with 50 age-and sex-matched apparently healthy controls (Group II) with no symptoms or signs on clinical examination or radiographic changes indicative of knee OA or other joint disease (15) . The practical part of the study was done at the Clinical and Chemical Pathology Department, Benha School of Medicine.
Patients were excluded from the study if they had one or more of the following: 1) isolated patello-femoral OA; 2) secondary OA due to trauma or deformity; metabolic disorders such as diabetes mellitus, thyroid disorders, or Cushing syndrome; or renal failure or were undergoing dialysis; 3) infectious disorders such as septic arthritis, viral arthritis, or fungal arthritis; 4) inflammatory arthritis such as rheumatoid arthritis, systemic lupus erythematosus, and sero-negative arthritis; 5) malignancy; 6) bilateral knee replacements; or 7) relatives included in the study.
Detailed histories of all the patients were obtained, and general examination and complete knee joint examination were performed. The body mass index (BMI) was calculated for all subjects included in the study as follows: the body mass was divided by the square of the body height. Clinically, the standardized Lequesne Algofunctional Index was used to evaluate disease severity through the assessment of pain/discomfort, maximum distance walked, and activities of daily living, with a maximum index score of 24 (16).
The affected knee was chosen on the basis of subjective symptoms and clinical signs, and X-radiography in the anteroposterior view in the weight-bearing position was performed, followed by graded according to the Kellgren-Lawrence (KL) grading system (17). Patients were classified as mild (if the KL grade was 1 or 2) and severe (if the KL grade was 3 or 4).
In total, 2 mL of venous blood was collected in EDTA-containing tubes from all subjects who participated in the study and stored immediately at -40°C till the time of DNA extraction.
Analysis of MATN3 polymorphism by RFLP (18):
Genotyping of MATN3 rs8176070 (SNP6) was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
DNA extraction DNA was extracted using the Thermo Scientific Gene JET Whole Blood Genomic DNA Purification Mini Kit (Thermo Fisher Scientific Inc; Catalog number: #K0781, Lot: 00242578, California, USA)
MATN3 genotyping
PCR was performed in a reaction volume of 50 μL using Dream Taq Green PCR Master Mix (Thermo Fisher Scientific Inc; Catalog number: #K1080 California, USA) (#K1080) with 25 μL dream taq green PCR master mix, 3 μL (5 pmol) forward primer, 3 μL (5 pmol) reverse primer, 5 μL (10 ng) template DNA, 14 μL nuclease-free water.
The PCR primers used were as follows: 5`d GGACAGGATCCCACAAAAAG 3` as a forward primer and 5`d GAAAGAGGGGCTACAACAGG 3` as a reverse primer (Biosearch Technologies, California, USA).
The amplification protocol was as follows: initial denaturation at 95°C for 10 min, followed by 35 cycles of denaturation at 95°C for 1 min, annealing at 60°C for 1 min, extending at 72°C for 1 min, and final extension at 72°C for 10 min in a thermocycler (Thermo Scientific PikoReal RealTime PCR System; California, USA). The resultant PCR products showed a single fragment at 501 bp by gel electrophoresis. In total, 10 μL of 501-bp product were digested with 10 units of BSEYI restriction enzyme (NEB-R0635S, Lot:0181412 USA) at 37°C for 10 h. Digestion products were visualized on a 2.5% agarose gel containing 2% ethidium bromide. RFLPs were coded as Bb, where the uppercase letter signifies the absence of the restriction site and the lowercase letter signifies the presence of the site. The wildtype genotype (CC), coded as bb, produced a double band at 149 and 352 bp; heterozygotes (CN), coded as Bb, produced three bands at 501, 149, and 352 bp; and homozygote polymorphic genotype (NN), coded as BB, produced only one band at 501 bp.
Statistical analysis
The Statistical Package of Social Sciences v. 16 .0 (SPSS Inc.; Chicago, IL, USA) computer program was used.
Descriptive statistics were calculated for the data in the form of mean and standard deviation (Mean±SD) for quantitative data. Qualitative data were expressed as number and percentage.
Analytical statistics
In statistical comparison between different groups, the statistical significance was defined as p≤0.05 (*), while a p-value of >0.05 was insignificant. A p-value of <0.001 was considered highly significant (**).
In the studied groups, the representativeness of alleles and genotypes was estimated by the Hardy-Weinberg equilibrium (HWE) by comparing the observed and expected frequencies of genetic variants. Logistic regression analysis was applied to examine association between SNP variants and the risk of OA. The differences in genotype and allele distributions were analyzed by the chi-square (χ2) test and represented by odds ratios (ORs) and 95% confidence intervals (CIs). A p-value of <0.05 was considered statistically significant at a confidence interval (CI) of 95%.
Results
The present study included 50 Egyptian patients with primary knee OA (Group I) and 50 apparently healthy volunteers (Group II).
Application of HWE revealed that genotypes of the MATN3 gene SNP6 (rs8 176070) in both cases and control subjects were independent (i.e., they were in HWE). There was no evidence to reject the assumption of HWE in the sample (p>0.001 for each). Table 1 presents the characteristics of the studied groups No significant differences between patients and controls were found with regard to age, sex distribution, and BMI (p=0.28, 0.14 and 0.9 respectively). As shown in Table 3 , with regard to the relation between the L-index score of severity and genotypes in patients with primary knee OA, there was a high statistically significant difference (p<0.001**) in the mean L-index score, with the score being higher in the B\b genotype with a mean±SD of 11.41±2.91. Patients with b\b and B\B genotypes had a mild grade according to the Lequesne score (Mean±SD 6.67±2.54 and 3.2±2.25, respectively).
The relation between KL grade and genotypes in primary knee OA patients is represented in Table 4 .
In this study, 25 patients (83.3%) with the B\b genotype had severe KL grades, with a highly significant difference compared with those with BB and bb genotypes (p<0.001**). Patients with the B\B genotype had mild KL (100%)-grading OA, while patients the b\b genotype had mild and severe KL-grading OA. This means that patients with the B\b genotype had worse radiological findings than those with B\B and b\b genotypes.
Discussion
Cartilaginous tissues contain a considerable amount of MATN-3 protein, which plays a vital role in the configuration of the collagen (collagen IX)-dependent network, linking cells together, and the collagen-independent pericellular network (19) .
The present case-control study investigated the possible association and clinical significance of MATN-3 gene rs8176070 (SNP6) in Egyptian patients with primary knee OA.
Our analysis revealed that with regard to the genotype B\b and b allele of MATN-3 gene SNP6 (rs8176070), a significant difference was found between OA patients and controls (p=0.046 and 0.042 respectively), with a high risk to develop OA (OR=2.250; 95% CI=1.011-5.008).
Previous studies have investigated the relationship between MATN-3 polymorphism and hand OA or knee OA (11, 13, 20) . Two articles have claimed that the SNP6 variation is associated with hand OA but not knee OA (13, 20), (10) . This may be explained by ethnic differences related to geographic distribution.
The present study also revealed a higher Lequesne score and KL grading of knee OA patients with the B\b genotype, while patients with the b\b genotype showed less severe disability and radiological severity than those with the B\b genotype. Patients with the B\B genotype had the lowest Lequesne score for disability, and their radiological findings were the mildest. This means that patients with the B\b genotype had worse clinical and radiological findings than other those with the B\B and b\b genotypes.
In a normal human cartilage, Pullig et al. (11) found low but significant expression of MATN-3 mRNA, which is extremely upregulated in an osteoarthritic cartilage and correlated with disease severity. They stated that MATN-3 could be used as an indicator of OA progression (21) .
In vitro studies of MATN-3 identified its anti-anabolic and pro-catabolic functions, suggesting that it plays an important role in OA (22, 23 Two studies conducted by Vincourt et al. (25, 26) revealed higher levels of MATN-3 in both the serum and synovial fluid of OA patients.
Matrilin-3 plays an important role in promoting ECM anabolism as it is considered as an adaptor protein; its function changes from an anabolic effect with a very low concentration range (100 to 200 ng/mL) to a catabolic effect when its levels change to a supra-physiological range (5 to 50 µg/mL) (25) . This may be related to a negative feedback mechanism (21).
Jayasurya et al. (27) noticed that even in the presence of interleukin-1β (IL-1β), a concentration of 100 and 200 ng/mL of the soluble recombinant MATN-3 in chondrocytes stimulates the induction of an interleukin 1 receptor antagonist (IL-1Ra), limits inflammation, and maintains the tensile and elastic strength of cartilaginous tissues through the enhancement of collagen II and aggrecan. On the other hand, it reduces disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS5) through IL-Ra. Further, in chondrocytes, MATN-3 downregulates matrix metalloproteinase-13 (MMP-13); thus, it plays a role in the inhibition of inflammation-induced hypertrophy (27) .
In contrast, Klatt et al. (28) reported that enhanced production of MMP1, MMP3, MMP13, IL-1β, IL-6, IL-8, iNOS, and COX-2 in primary human chondrocytes was induced by high concentrations (5 to 50 µg/mL) of MATN-3 with consequently increased inflammation and catabolism of ECM. In addition, elevated levels of the free form of MATN-3 resulting from the degradation of ECM were induced by the overexpression of ADAMTS4 and ADAMTS5 (28).
In conclusion, the investigated polymorphism in the MATN-3 gene may reflect the risk and severity of knee OA in the Egyptian population, particularly with the B\b genotype.
Limitations
Because of the relatively small sample size, these results require to be confirmed by further studies in different populations with a large sample size to highlight the possible relation between the MATN3 gene and OA.
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